Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing

Biotechnology and Bioengineering

Volumn 106, Issue 4, 2010, Pages 598-607

  Berting, Andreas ^a   Farcet, Maria R ^a   Kreil, Thomas R ^a  

^a BAXTER BIOSCIENCE   (Austria)

Author keywords

Adventitious agent testing; Baby hamster kidney (BHK) cells; Biopharmaceuticals; Chinese hamster ovary (CHO) cells; Recombinant products; Virus safety

Indexed keywords

ADVENTITIOUS AGENT TESTING; BIOPHARMACEUTICALS; CHINESE HAMSTER OVARY CELLS; HAMSTER KIDNEYS;

CELL CULTURE; COMPUTER VIRUSES; HARVESTING; SAFETY TESTING; VIRUSES;

CELLS;

ANIMAL CELL; ARTICLE; BOVINE DIARRHEA VIRUS; CELL DIVISION; CHO CELL; COXSACKIE VIRUS B; CYTOPATHOGENIC EFFECT; ENCEPHALOMYOCARDITIS VIRUS; FOWL PLAGUE VIRUS; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; INFECTION SENSITIVITY; INFLUENZA VIRUS A; MAMMALIAN ORTHOREOVIRUS; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PARAINFLUENZA VIRUS 3; PARVOVIRUS; PORCINE PARVOVIRUS; ROSS RIVER ALPHA VIRUS; SAFETY; VESICULAR STOMATITIS VIRUS; VIRAL CONTAMINATION; VIRUS INFECTION;

ANIMALS; CELL CULTURE TECHNIQUES; CHO CELLS; CRICETINAE; CRICETULUS; DRUG CONTAMINATION; TECHNOLOGY, PHARMACEUTICAL; VIRUSES;

CRICETINAE; CRICETULUS GRISEUS;

EID: 77954288264     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22723     Document Type: Article

References (74)

1. Aradaib IE, Wilson WC, Schore CE, Mohammed ME, Yilma TD, Cullor JS, Osburn BI. 1998. PCR detection of North American and Central African isolates of epizootic hemorrhagic disease virus (EHDV) based on genome segment 10 of EHDV serotype 1. J Clin Microbiol 36:2604-2608.
2. Carrillo C, Lu Z, Borca MV, Vagnozzi A, Kutish GF, Rock DL. 2007. Genetic and phenotypic variation of foot-and-mouth disease virus during serial passages in a natural host. J Virol 81:11341-11351.
3. Chen YT, Lin CH, Ji WT, Li SK, Liu HJ. 2008. Proteasome inhibition reduces avian reovirus replication and apoptosis induction in cultured cells. J Virol Methods 151:95-100.
4. Chinchar VG, Bryan L, Wang J, Long S, Chinchar GD. 2003. Induction of apoptosis in frog virus 3-infected cells. Virology 306:303-312.
5. Chu VC, Whittaker GR. 2004. Influenza virus entry and infection require host cell N-linked glycoprotein. Proc Natl Acad Sci USA 101:18153-18158.
6. Chulu JL, Lee LH, Lee YC, Liao SH, Lin FL, Shih WL, Liu HJ. 2007. Apoptosis induction by avian reovirus through p53 and mitochondria-mediated pathway. Biochem Biophys Res Commun 356:529-535.
7. Condon RG, Schaefer EJ, Santoro M, Longley R, Tsao YS, Zurawski SM, Liu Z. 2003. Development of a Chinese hamster ovary cell line for recombinant adenovirus-mediated gene expression. Biotechnol Prog 19:137-143.
8. Conner J, Rixon FJ, Brown SM. 2005. Herpes simplex virus type 1 strain HSV1716 grown in baby hamster kidney cells has altered tropism for nonpermissive Chinese hamster ovary cells compared to HSV1716 grown in Vero cells. J Virol 79:9970-9981.
9. Connor JH, McKenzie MO, Lyles DS. 2006. Role of residues 121 to 124 of vesicular stomatitis virus matrix protein in virus assembly and virus-host interaction. J Virol 80:3701-3711.
10. De BP, Lesoon A, Banerjee AK. 1991. Human parainfluenza virus type 3 transcription in vitro: Role of cellular actin in mRNA synthesis. J Virol 65:3268-3275.
11. De LC, Scavia G, Lorenzetti R, Scaramozzino P, Amaddeo D, Cardeti G, Scicluna M, Ferrari G, Autorino GL. 2005. Identification of Culicoides obsoletus (Diptera: Ceratopogonidae) as a vector of bluetongue virus in central Italy. Vet Rec 156:301-304.
12. Ellenberg P, Linero FN, Scolaro LA. 2007. Superinfection exclusion in BHK-21 cells persistently infected with Junin virus. J Gen Virol 88:2730-2739.
13. FDA. 1997. Points to consider in the manufacture and testing of monoclonal antibody products for human use; available at http://www.fda.-gov/ downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ OtherRecommendationsforManufacturers/ UCM153182.pdf (last accessed January 21, 2010).
14. FDA. 1998. Guidance for industry: Q5A viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; available at http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm073454.pdf (last accessed January 21, 2010).
15. FDA. 2006. Guidance for industry: Characterization and qualification of cell substrates and other biological starting materials used in the production of viral vaccines for the prevention and treatment of infectious diseases; available at http://www.fda.gov/downloads/BiologicsBlood-Vaccines/ GuidanceComplianceRegulatoryInformation/Guidances/ Vaccines/ucm092122.pdf (last accessed January 21, 2010).
16. Francis MJ. 2003. Propagation of bovine coronavirus in chinese hamster ovary cells. United States Patent 6514502: Schering-Plough Veterinary Corporation.
17. Gaillard RK, Joklik WK. 1985. The relative translation efficiencies of reovirus messenger RNAs. Virology 147:336-348.
18. Garcia-Briones M, Rosas MF, Gonzalez-Magaldi M, Martin-Acebes MA, Sobrino F, Armas-Portela R. 2006. Differential distribution of nonstructural proteins of foot-and-mouth disease virus in BHK-21 cells. Virology 349:409-421.
19. Garnick RL. 1996. Experience with viral contamination in cell culture. Dev Biol Stand 88:49-56.
20. Garnick RL. 1998. Raw materials as a source of contamination in large-scale cell culture. Dev Biol Stand 93:21-29.
21. Genzyme. 2009. Genzyme temporarily interrupts production at Allston plant. Press release, June 16, 2009; available at http://www.genzyme.-com/corp/ media/GENZ%20PR-061609.asp (last accessed January 21, 2010).
22. Gillet L, Gill MB, Colaco S, Smith CM, Stevenson PG. 2006. Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice. J Gen Virol 87:3515-3527.
23. Gorchakov R, Frolova E, Sawicki S, Atasheva S, Sawicki D, Frolov I. 2008. A new role for ns polyprotein cleavage in Sindbis virus replication. J Virol 82:6218-6231.
24. Goto A, Hayasaka D, Yoshii K, Mizutani T, Kariwa H, Takashima I. 2003. A BHK-21 cell culture-adapted tick-borne encephalitis virus mutant is attenuated for neuroinvasiveness. Vaccine 21:4043-4051.
25. Govorkova EA, Matrosovich MN, Tuzikov AB, Bovin NV, Gerdil C, Fanget B, Webster RG. 1999. Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells. Virology 262:31-38.
26. Grillberger L, Kreil TR, Nasr S, Reiter M. 2009. Emerging trends in plasmafree manufacturing of recombinant protein therapeutics expressed in mammalian cells. Biotechnol J 4:186-201.
27. He B, Paterson RG, Stock N, Durbin JE, Durbin RK, Goodbourn S, Randall RE, Lamb RA. 2002. Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: The multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology 303:15-32.
28. Hösel M, Webb D, Schröer J, Doerfler W. 2003. The abortive infection of Syrian hamster cells with human adenovirus type 12. Curr Top Microbiol Immunol 272:415-440. (Pubitemid 36458336)
29. Jia H, Ge X, Guo X, Yang H, Yu K, Chen Z, Chen Y, Cha Z. 2008. Specific small interfering RNAs-mediated inhibition of replication of porcine encephalomyocarditis virus in BHK-21 cells. Antiviral Res 79:95-104.
30. Kallel H, Jouini A, Majoul S, Rourou S. 2002. Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells. J Biotechnol 95:195-204.
31. Kiiver K, Merits A, Sarand I. 2008. Novel vectors expressing anti-apoptotic protein Bcl-2 to study cell death in Semliki Forest virus-infected cells. Virus Res 131:54-64.
32. Knowles NJ, Buckley LS, Pereira HG. 1979. Classification of porcine enteroviruses by antigenic analysis and cytopathic effects in tissue culture: Description of 3 new serotypes. Arch Virol 62:201-208.
33. Kumari K, Gulati S, Smith DF, Gulati U, Cummings RD, Air GM. 2007. Receptor binding specificity of recent human H3N2 influenza viruses. Virol J 4:42.
34. Li Z, Yang P, Liu H, Li WX. 2002. A new indicator cell line to monitor human foamy virus infection and stability in vitro. Intervirology 45:79-84.
35. Lopez T, Lopez S, Arias CF. 2006. Heat shock enhances the susceptibility of BHK cells to rotavirus infection through the facilitation of entry and post-entry virus replication steps. Virus Res 121:74-83.
36. Malathi J, Therese KL, Madhavan HN. 2001. The association of rubella virus in congenital cataract - a hospital-based study in India. J Clin Virol 23:25-29.
37. Marsh M, Bron R. 1997. SFV infection in CHO cells: Cell-type specific restrictions to productive virus entry at the cell surface. J Cell Sci 110:95-103. (Pubitemid 27057948)
38. Matsuyama S, Taguchi F. 2000. Impaired entry of soluble receptor-resistant mutants of mouse hepatitis virus into cells expressing MHVR2 receptor. Virology 273:80-89.
39. McCammon JR, Riesser VW. 1979. Effects of ribavirin on BHK-21 cells acutely or persistently infected with mumps virus. Antimicrob Agents Chemother 15:356-360. (Pubitemid 9206226)
40. McLean DM, Grass PN, Judd BD, Stolz KJ, Wong KK. 1978. Transmission of Northway and St. Louis encephalitis viruses by arctic mosquitoes. Arch Virol 57:315-322.
41. Misinzo G, Delputte PL, Meerts P, Lefebvre DJ, Nauwynck HJ. 2006. Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells. J Virol 80:3487-3494.
42. Najera JL, Gomez CE, Domingo-Gil E, Gherardi MM, Esteban M. 2006. Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene. J Virol 80:6033-6047.
43. Nettleton PF, Rweyemamu MM. 1980. The association of calf serum with the contamination of BHK21 clone 13 suspension cells by a parvovirus serologically related to the minute virus of mice (MVM). Arch Virol 64:359-374.
44. Ng CY, Gu F, Phong WY, Chen YL, Lim SP, Davidson A, Vasudevan SG. 2007. Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing. Antiviral Res 76:222-231.
45. Nims RW. 2006. Detection of adventitious viruses in biologicals - a rare occurrence. Dev Biol 123:153-164.
46. Nishio M, Tsurudome M, Ito M, Garcin D, Kolakofsky D, Ito Y. 2005. Identification of paramyxovirus V protein residues essential for STAT protein degradation and promotion of virus replication. J Virol 79:8591-8601.
47. Nishio M, Nagata A, Yamamoto A, Tsurudome M, Ito M, Kawano M, Komada H, Ito Y. 2006. The properties of recombinant Sendai virus having the P gene of Sendai virus pi strain derived from BHK cells persistently infected with Sendai virus. Med Microbiol Immunol 195:151-158.
48. Nixdorf R, Schmidt J, Karger A, Mettenleiter TC. 1999. Infection of Chinese hamster ovary cells by pseudorabies virus. J Virol 73:8019-8026. (Pubitemid 29441661)
49. Oehmig A, Buttner M, Weiland F, Werz W, Bergemann K, Pfaff E. 2003. Identification of a calicivirus isolate of unknown origin. J Gen Virol 84:2837-2845.
50. Onions D. 2004. Animal virus contaminants of biotechnology products. Dev Biol 118:155-163.
51. Patkar CG, Kuhn RJ. 2008. Yellow Fever virus NS3 plays an essential role in virus assembly independent of its known enzymatic functions. J Virol 82:3342-3352.
52. Petrakova O, Volkova E, Gorchakov R, Paessler S, Kinney RM, Frolov I. 2005. Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in mammalian cells. J Virol 79:7597-7608.
53. Potts BJ. 2008. Characterization of viral cell culture contamination. Presentation at the PDA Virus and TSE Safety Forum, June 3-5, Berlin, Germany.
54. Puig-Basagoiti F, Tilgner M, Bennett CJ, Zhou Y, Munoz-Jordan JL, Garcia-Sastre A, Bernard KA, Shi PY. 2007. A mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesis. Virology 361:229-241.
55. Rabenau H, Ohlinger V, Anderson J, Selb B, Cinatl J, Wolf W, Frost J, Mellor P, Doerr HW. 1993. Contamination of genetically engineered CHO-cells by epizootic haemorrhagic disease virus (EHDV). Biologicals 21:207-214.
56. Salanueva IJ, Novoa RR, Cabezas P, Lopez-Iglesias C, Carrascosa JL, Elliott RM, Risco C. 2003. Polymorphism and structural maturation of bunyamwera virus in Golgi and post-Golgi compartments. J Virol 77:1368-1381.
57. Sanz MA, Castello A, Carrasco L. 2007. Viral translation is coupled to transcription in Sindbis virus-infected cells. J Virol 81:7061-7068.
58. Shanmukhappa K, Kim JK, Kapil S. 2007. Role of CD151, a tetraspanin, in porcine reproductive and respiratory syndrome virus infection. Virol J 4:62.
59. Shimokata K, Ito Y, Nishiyama Y, Kimura Y. 1981. Plaque formation by human-origin parainfluenza type 2 virus in established cell lines. Arch Virol 67:355-360.
60. Slivac I, Srcek VG, Radosevic K, Kmetic I, Kniewald Z. 2006. Aujeszky's disease virus production in disposable bioreactor. J Biosci 31:363-368.
61. Slosaris M, Levy B, Katz E, Levy R, Zakay-Rones Z. 1989. Elevated virulence of Newcastle disease virus strains following serial passages in kidney cells in vitro. Avian Dis 33:248-253.
62. Smyth M, Symonds A, Brazinova S, Martin J. 2002. Bovine enterovirus as an oncolytic virus: Foetal calf serum facilitates its infection of human cells. Int J Mol Med 10:49-53.
63. Son KN, Becker RP, Kallio P, Lipton HL. 2008. Theiler's virus-induced intrinsic apoptosis in M1-D macrophages is Bax mediated and restricts virus infectivity: A mechanism for persistence of a cytolytic virus. J Virol 82:4502-4510.
64. Su HL, Liao CL, Lin YL. 2002. Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response. J Virol 76:4162-4171.
65. Takano-Maruyama M, Ohara Y, Asakura K, Okuwa T. 2006. Theiler's murine encephalomyelitis virus leader protein amino acid residue 57 regulates subgroup-specific virus growth on BHK-21 cells. J Virol 80: 12025-12031.
66. Tsai KN, Tsang SF, Huang CH, Chang RY. 2007. Defective interfering RNAs of Japanese encephalitis virus found in mosquito cells and correlation with persistent infection. Virus Res 124:139-150.
67. Vagnozzi A, Stein DA, Iversen PL, Rieder E. 2007. Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers. J Virol 81:11669-11680.
68. Walsh G. 2006. Biopharmaceutical benchmarks. Nature Biotech 24:769-776.
69. Weir EC, Brownstein DG, Smith AL, Johnson EA. 1988. Respiratory disease and wasting in athymic mice infected with pneumonia virus of mice. Lab Anim Sci 38:133-137.
70. Widman DG, Ishikawa T, Fayzulin R, Bourne N, Mason PW. 2008. Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system. Vaccine 26:2762-2771.
71. Wisher M. 2005. BioReliance: From cell line to product - current concepts in biologics safety testing; pre-clinical safety testing of biopharmaceutical products - latest regulatory and technical considerations. Presentation; available at http://cgi.iweb.nuri.net/cgibank/data/board/swsciens/library/ The%20Rationale%20for%20Cell%20Line%20Characterisation. pdf (last accessed January 21, 2010).
72. Wurm FM. 2004. Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotech 22:1393-1398.
73. Zautner AE, Jahn B, Hammerschmidt E, Wutzler P, Schmidtke M. 2006. N-and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells. J Virol 80:6629-6636.
74. Zoletto R. 1985. Parvovirus serologically related to the minute virus of mice (MVM) as contaminant of BHK 21 cl. 13 suspension cells. Dev Biol Stand 60:179-183.